America Great Health (AAGH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Quarterly

0 500K 1M 1.5M Q2 '16: 1.5M Q3 '16: 0 Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 5.5K Q1 '21: 136 Q2 '21: 0 Q3 '21: 195.5K Q4 '21: 0 Q1 '22: 0 Q2 '22: 155.7K Q3 '22: 2.7K Q1 '23: 51.9K Q2 '23: 38.2K Q3 '23: 39.5K Q4 '23: 74.7K Q1 '24: 13.8K Q2 '24: 91.2K Q3 '24: 94K Q4 '24: 95.7K Q1 '25: 140.1K Q2 '25: 90.9K Q3 '25: 56.1K Q4 '25: 104.5K Q1 '26: 187.6K Q2 '26: 45.1K Q3 '26: 26.1K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q1 '24 Q2 '25 Q3 '26

Gross Profit Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q3 '16: 0 Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 2.1K Q1 '21: -8 Q2 '21: 0 Q3 '21: 51.6K Q4 '21: -269 Q1 '22: 0 Q2 '22: -1.4M Q3 '22: 2.4K Q4 '22: -90.9K Q1 '23: 24.4K Q2 '23: 30.2K Q3 '23: 39.3K Q4 '23: 74.7K Q1 '24: 13.6K Q2 '24: 82.7K Q3 '24: 82.1K Q4 '24: -8.6K Q1 '25: 128.8K Q2 '25: 83.1K Q3 '25: 49.8K Q4 '25: 77.4K Q1 '26: 112.7K Q2 '26: 36.5K Q3 '26: 22.5K Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Operating Income Quarterly

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q1 '15: -158.8K Q1 '16: -683.4K Q1 '18: -12.9K Q2 '18: -15.1K Q3 '18: -9.1K Q4 '18: -21.1K Q1 '19: -5.9K Q2 '19: -24.5K Q3 '19: -7.5K Q4 '19: -8.8K Q1 '20: -2.2K Q2 '20: -10K Q3 '20: -1.5K Q4 '20: -32.5K Q1 '21: -1.2K Q2 '21: -34.6K Q3 '21: -47.1K Q4 '21: -160.7K Q1 '22: -298.1K Q2 '22: -1.8M Q3 '22: -647.3K Q4 '22: -2M Q1 '23: -128.2K Q2 '23: -95.1K Q3 '23: -111.7K Q4 '23: -157.6K Q1 '24: -74.9K Q2 '24: -153.9K Q3 '24: -134.3K Q4 '24: -419.6K Q1 '25: -70.9K Q2 '25: -120.5K Q3 '25: -85.3K Q4 '25: -106.2K Q1 '26: -3.4K Q2 '26: -198.8K Q3 '26: -73.8K Q1 '16 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Net Income Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q4 '16: -68K Q1 '17: -58K Q2 '17: -860.7K Q3 '17: -12.1K Q4 '17: -36.2K Q1 '18: -13.7K Q2 '18: -15.1K Q3 '18: -9.1K Q4 '18: -21.5K Q1 '19: -7.6K Q2 '19: -36.5K Q3 '19: -7.5K Q4 '19: -13.3K Q1 '20: -4.1K Q2 '20: -11.2K Q3 '20: -2.7K Q4 '20: -33.9K Q1 '21: -2.7K Q2 '21: -36.3K Q3 '21: -49.2K Q4 '21: -180.9K Q1 '22: -331.3K Q2 '22: -1.8M Q3 '22: -609.5K Q4 '22: -2.2M Q1 '23: -192.8K Q2 '23: -124.6K Q3 '23: -212.7K Q4 '23: -241.8K Q1 '24: -156.4K Q2 '24: -248.3K Q3 '24: -226.6K Q4 '24: -589.3K Q1 '25: -145.4K Q2 '25: -193.1K Q3 '25: -158.4K Q4 '25: -222.2K Q1 '26: -85.4K Q2 '26: 1.1M Q3 '26: -166K Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Cost of Revenue Quarterly

0 600K 1.2M 1.8M Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 3.4K Q1 '21: 144 Q2 '21: 0 Q3 '21: 143.9K Q4 '21: 269 Q1 '22: 0 Q2 '22: 1.6M Q3 '22: 360 Q4 '22: 37.1K Q1 '23: 27.5K Q2 '23: 8K Q3 '23: 190 Q4 '23: 32 Q1 '24: 177 Q2 '24: 8.5K Q3 '24: 11.9K Q4 '24: 104.3K Q1 '25: 11.3K Q2 '25: 7.8K Q3 '25: 6.3K Q4 '25: 27.1K Q1 '26: 74.9K Q2 '26: 8.6K Q3 '26: 3.6K Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Operating Cash Flow Quarterly

-750K -500K -250K 0 250K 500K 750K Q4 '16: -10.7K Q1 '17: -46.3K Q2 '17: 35.7K Q3 '17: -12.2K Q4 '17: -28.3K Q1 '18: -7K Q2 '18: -18.8K Q3 '18: -4.8K Q4 '18: -16.2K Q1 '19: -99 Q2 '19: -23.9K Q3 '19: -2.8K Q4 '19: -1K Q1 '20: -2.8K Q2 '20: -12.6K Q3 '20: -1.7K Q4 '20: -22.5K Q1 '21: -2.2K Q2 '21: -595 Q3 '21: -94.2K Q4 '21: -232.2K Q1 '22: -459.2K Q2 '22: -152.7K Q3 '22: -707.1K Q4 '22: -160.9K Q1 '23: -143.2K Q2 '23: -72.4K Q3 '23: -202.3K Q4 '23: 28.1K Q1 '24: -46.7K Q2 '24: -285K Q3 '24: -118.5K Q4 '24: -165.4K Q1 '25: -95.6K Q2 '25: 88.8K Q3 '25: -53.5K Q4 '25: -272.6K Q1 '26: 44.5K Q2 '26: -126.5K Q3 '26: 1.7K Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Free Cash Flow Quarterly

-750K -500K -250K 0 250K 500K 750K Q1 '13: -41.8K Q2 '13: -10.5K Q3 '13: -2.5K Q1 '21: -2.2K Q2 '21: -595 Q3 '21: -94.2K Q4 '21: -244.9K Q1 '22: -471.9K Q2 '22: -156.7K Q3 '22: -707.1K Q4 '22: -160.9K Q1 '23: -143.2K Q2 '23: -116.8K Q3 '23: -202.3K Q4 '23: 28.1K Q1 '24: -46.7K Q2 '24: -285K Q3 '24: -118.5K Q4 '24: -165.4K Q1 '13 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 8B 16B 24B Q1 '18: 20.2B Q2 '18: 20.2B Q3 '18: 20.2B Q1 '19: 20.2B Q2 '19: 20.2B Q3 '19: 20.2B Q1 '24: 21.1B Q2 '24: 21.1B Q3 '24: 21.1B Q1 '25: 21.1B Q2 '25: 21.1B Q3 '25: 21.2B Q1 '26: 21.2B Q2 '26: 21.2B Q3 '26: 21.2B Q1 '18 Q3 '18 Q2 '19 Q1 '24 Q3 '24 Q2 '25 Q1 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 Q1 '15: 0.00 Q2 '15: 0.00 Q3 '15: 0.00 Q4 '15: 0.00 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: 0.00 Q1 '17: 0.00 Q2 '17: 0.00 Q3 '17: 0.00 Q4 '17: 0.00 Q1 '18: 0.00 Q2 '18: 0.00 Q3 '18: 0.00 Q4 '18: 0.00 Q1 '19: 0.00 Q2 '19: 0.00 Q3 '19: 0.00 Q4 '19: 0.00 Q1 '20: 0.00 Q2 '20: 0.00 Q3 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q1 '22: 0.00 Q2 '22: 0.00 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '26: 0.00 Q3 '26: 0.00 Q1 '16 Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q2 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.